APA (7th ed.) Citation

MS, T., M, M., JN, A., SM, A., JA, B., JE, A., . . . JL, C. (2025). Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: Primary analysis of the ELM-1 study. Blood, 145(14), 1498. https://doi.org/10.1182/blood.2024027044

Chicago Style (17th ed.) Citation

MS, Topp, et al. "Odronextamab Monotherapy in R/R DLBCL After Progression with CAR T-cell Therapy: Primary Analysis of the ELM-1 Study." Blood 145, no. 14 (2025): 1498. https://doi.org/10.1182/blood.2024027044.

MLA (9th ed.) Citation

MS, Topp, et al. "Odronextamab Monotherapy in R/R DLBCL After Progression with CAR T-cell Therapy: Primary Analysis of the ELM-1 Study." Blood, vol. 145, no. 14, 2025, p. 1498, https://doi.org/10.1182/blood.2024027044.